Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention (PCI)-Results of the FERARI study.
Becher T, Behnes M, Ünsal M, Baumann S, El-Battrawy I, Fastner C, Kuschyk J, Papavassiliu T, Hoffmann U, Mashayekhi K, Borggrefe M, Akin I. Becher T, et al. Among authors: akin i. Cardiovasc Revasc Med. 2016 Dec;17(8):505-509. doi: 10.1016/j.carrev.2016.05.008. Epub 2016 Jun 15. Cardiovasc Revasc Med. 2016. PMID: 27350417
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
Akin I, Tölg R, Hochadel M, Bergmann MW, Khattab AA, Schneider S, Senges J, Kuck KH, Richardt G, Nienaber CA; DES.DE (German Drug-Eluting Stent) Study Group. Akin I, et al. JACC Cardiovasc Interv. 2012 Feb;5(2):162-9. doi: 10.1016/j.jcin.2011.09.021. JACC Cardiovasc Interv. 2012. PMID: 22361600 Free article.
The Use of Novel Oral Anticoagulants in Atrial Fibrillation.
Ansari U, Behnes M, Fastner C, Akin I. Ansari U, et al. Among authors: akin i. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):97-100. doi: 10.2174/1871529x1502151209111019. Cardiovasc Hematol Disord Drug Targets. 2015. PMID: 26666325 Review.
New Oral Anticoagulants in Coronary Artery Disease.
Behnes M, Fastner C, Ansari U, Akin I. Behnes M, et al. Among authors: akin i. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):101-5. doi: 10.2174/1871529x1502151209111429. Cardiovasc Hematol Disord Drug Targets. 2015. PMID: 26666326 Review.
New Oral Anticoagulation after Heart Valve Replacement.
El-Battrawy I, Baumann S, Huseynov A, Akin I. El-Battrawy I, et al. Among authors: akin i. Cardiovasc Hematol Disord Drug Targets. 2015;15(2):106-9. doi: 10.2174/1871529x1502151209111735. Cardiovasc Hematol Disord Drug Targets. 2015. PMID: 26666327 Review.
Left atrial appendage morphology, echocardiographic characterization, procedural data and in-hospital outcome of patients receiving left atrial appendage occlusion device implantation: a prospective observational study.
Fastner C, Behnes M, Sartorius B, Yildiz M, Mashayekhi K, El-Battrawy I, Lehmann R, Baumann S, Becher T, Borggrefe M, Akin I. Fastner C, et al. Among authors: akin i. BMC Cardiovasc Disord. 2016 Jan 28;16:25. doi: 10.1186/s12872-016-0200-z. BMC Cardiovasc Disord. 2016. PMID: 26822890 Free PMC article.
889 results